FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 20623955 · Received November 6, 2024

Report

Report Number
1823260-2024-03215
Event Type
Malfunction
Date Received
November 6, 2024
Date of Event
October 11, 2024
Report Date
November 6, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE CALCIUM REAGENT LOT NUMBER IS 803015 AND THE MAGNESIUM REAGENT LOT NUMBER IS 788195. THE EXPIRATION DATES WERE NOT PROVIDED. THE QC RESULTS WERE ACCEPTABLE. THE CALIBRATION FOR CALCIUM WAS ACCEPTABLE. THE CALIBRATION FOR MAGNESIUM WAS NOT PROVIDED. A GENERAL REAGENT ISSUE WAS EXCLUDED. THE ALARM TRACE SHOWED ABNORMAL SAMPLE ASPIRATION ALARMS, WHICH ARE INDICATIVE OF POOR SAMPLE QUALITY. THE FIELD SERVICE REPRESENTATIVE FOUND THE SAMPLE PROBE WAS CONTAMINATED. HE VALIDATED THE CELL RINSE VOLUME, CLEANED THE WASHING STATION, CLEANED THE SAMPLE PROBE, AND FLUSHED THE SAMPLE LINE. HE PERFORMED TESTS WITH ACCEPTABLE RESULTS. AFTER SERVICE, NO ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE CALCIUM GEN.2 AND ROCHE DIAGNOSTICS MAGNESIUM REAGENT RESULTS FOR 1 PATIENT SAMPLE ON A COBAS C 503 ANALYTICAL UNIT. THE INITIAL CALCIUM RESULT WAS 5.8 MG/DL AND THE REPEATED RESULT WAS 7.5 MG/DL. THE INITIAL MAGNESIUM RESULT WAS <0.5 MG/DL AND THE REPEATED RESULT WAS 1.5 MG/DL. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THE SAMPLE WAS REPEATED DUE TO THE INITIAL RESULTS BEING LOW. THE REPEATED RESULTS WERE BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1999007 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown